- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
June 5th, 2007
Im's research could have applications in nanotechnology and pharmaceuticals.
"The aim of our work is to understand human disease at the molecular level," said Im. "If you look at the drugs that we're using now, about 50 percent of commercial drugs are targeting membrane proteins. As our research progresses, we hope to help make a map to develop the drugs of the future."
A committee of researchers reviews more than 500 nominations each year to determine a final selection of 116 Sloan fellows in seven scientific fields.
|Related News Press|
Scientists 'see' detailed make-up of deadly toxin for the first time: Exciting advance provides hope for developing novel potential method of treating pneumococcal diseases such as bacterial pneumonia, meningitis and septicaemia November 25th, 2015
Electric fields remove nanoparticles from blood with ease November 24th, 2015
Production of Nanocapsules Containing Omega-3 Powder in Iran November 24th, 2015
Using light-force to study single molecules November 23rd, 2015
Medical and aerospace electronics powered by Picosun ALD November 26th, 2015
Scientists design a QKD-based quantum private query with no failure November 25th, 2015
MIT mathematicians identify limits to heat flow at the nanoscale: New formula identifies limits to nanoscale heat transfer, may help optimize devices that convert heat to electricity November 25th, 2015
Physicists explain the unusual behavior of strongly disordered superconductors: Using a theory they developed previously, the scientists have linked superconducting carrier density with the quantum properties of a substance November 25th, 2015
New 'self-healing' gel makes electronics more flexible November 25th, 2015
GLOBALFOUNDRIES Receives Quality Award from INOVA Semiconductors GmbH November 20th, 2015
New method developed to predict response to nanotherapeutics: Taking a precision medicine approach to nanomedicine, researchers use MR imaging with magnetic nanoparticles to predict which tumors may be more responsive to therapeutic nanoparticles November 18th, 2015